These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The activity of the murine Bax promoter is regulated by Sp1/3 and E-box binding proteins but not by p53. Schmidt T; Körner K; Karsunky H; Korsmeyer S; Müller R; Möröy T Cell Death Differ; 1999 Sep; 6(9):873-82. PubMed ID: 10510469 [TBL] [Abstract][Full Text] [Related]
4. Distinct promoter elements mediate the co-operative effect of Brn-3a and p53 on the p21 promoter and their antagonism on the Bax promoter. Perez-Sanchez C; Budhram-Mahadeo VS; Latchman DS Nucleic Acids Res; 2002 Nov; 30(22):4872-80. PubMed ID: 12433990 [TBL] [Abstract][Full Text] [Related]
5. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Miyashita T; Reed JC Cell; 1995 Jan; 80(2):293-9. PubMed ID: 7834749 [TBL] [Abstract][Full Text] [Related]
6. A conserved intronic response element mediates direct p53-dependent transcriptional activation of both the human and murine bax genes. Thornborrow EC; Patel S; Mastropietro AE; Schwartzfarb EM; Manfredi JJ Oncogene; 2002 Feb; 21(7):990-9. PubMed ID: 11850816 [TBL] [Abstract][Full Text] [Related]
7. The tumor suppressor protein p53 requires a cofactor to activate transcriptionally the human BAX promoter. Thornborrow EC; Manfredi JJ J Biol Chem; 2001 May; 276(19):15598-608. PubMed ID: 11278953 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of HIF-1- and wild-type p53-stimulated transcription by codon Arg175 p53 mutants with selective loss of functions. Blagosklonny MV; Giannakakou P; Romanova LY; Ryan KM; Vousden KH; Fojo T Carcinogenesis; 2001 Jun; 22(6):861-7. PubMed ID: 11375890 [TBL] [Abstract][Full Text] [Related]
9. p53 mutants can often transactivate promoters containing a p21 but not Bax or PIG3 responsive elements. Campomenosi P; Monti P; Aprile A; Abbondandolo A; Frebourg T; Gold B; Crook T; Inga A; Resnick MA; Iggo R; Fronza G Oncogene; 2001 Jun; 20(27):3573-9. PubMed ID: 11429705 [TBL] [Abstract][Full Text] [Related]
10. Adenovirus-mediated overexpression of p14(ARF) induces p53 and Bax-independent apoptosis. Hemmati PG; Gillissen B; von Haefen C; Wendt J; Stärck L; Güner D; Dörken B; Daniel PT Oncogene; 2002 May; 21(20):3149-61. PubMed ID: 12082630 [TBL] [Abstract][Full Text] [Related]
11. Association between cisplatin resistance and mutation of p53 gene and reduced bax expression in ovarian carcinoma cell systems. Perego P; Giarola M; Righetti SC; Supino R; Caserini C; Delia D; Pierotti MA; Miyashita T; Reed JC; Zunino F Cancer Res; 1996 Feb; 56(3):556-62. PubMed ID: 8564971 [TBL] [Abstract][Full Text] [Related]
12. The intrinsic radioresistance of glioblastoma-derived cell lines is associated with a failure of p53 to induce p21(BAX) expression. Shu HK; Kim MM; Chen P; Furman F; Julin CM; Israel MA Proc Natl Acad Sci U S A; 1998 Nov; 95(24):14453-8. PubMed ID: 9826721 [TBL] [Abstract][Full Text] [Related]
13. One mechanism for cell type-specific regulation of the bax promoter by the tumor suppressor p53 is dictated by the p53 response element. Thornborrow EC; Manfredi JJ J Biol Chem; 1999 Nov; 274(47):33747-56. PubMed ID: 10559267 [TBL] [Abstract][Full Text] [Related]
14. Effects of wild-type and mutated p53 and Id proteins on the induction of apoptosis by adenovirus E1A, c-Myc, Bax, and Nip3 in p53 null mouse cerebellum cells. Tsunoda H; Terasawa T; Yageta M; Nakajima T; Tomooka Y; Tsuchida N; Oda K Biochem Biophys Res Commun; 1999 Feb; 255(3):722-30. PubMed ID: 10049778 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of the NF-kappa B transcription factor increases Bax expression in cancer cell lines. Bentires-Alj M; Dejardin E; Viatour P; Van Lint C; Froesch B; Reed JC; Merville MP; Bours V Oncogene; 2001 May; 20(22):2805-13. PubMed ID: 11420692 [TBL] [Abstract][Full Text] [Related]
16. Tissue specific expression of p53 target genes suggests a key role for KILLER/DR5 in p53-dependent apoptosis in vivo. Burns TF; Bernhard EJ; El-Deiry WS Oncogene; 2001 Aug; 20(34):4601-12. PubMed ID: 11498783 [TBL] [Abstract][Full Text] [Related]
17. Novel human p53 mutations that are toxic to yeast can enhance transactivation of specific promoters and reactivate tumor p53 mutants. Inga A; Resnick MA Oncogene; 2001 Jun; 20(26):3409-19. PubMed ID: 11423991 [TBL] [Abstract][Full Text] [Related]
18. Role of p53 and NF-kappaB in epigallocatechin-3-gallate-induced apoptosis of LNCaP cells. Hastak K; Gupta S; Ahmad N; Agarwal MK; Agarwal ML; Mukhtar H Oncogene; 2003 Jul; 22(31):4851-9. PubMed ID: 12894226 [TBL] [Abstract][Full Text] [Related]
19. The Brn-3a transcription factor inhibits the pro-apoptotic effect of p53 and enhances cell cycle arrest by differentially regulating the activity of the p53 target genes encoding Bax and p21(CIP1/Waf1). Budram-Mahadeo V; Morris PJ; Latchman DS Oncogene; 2002 Sep; 21(39):6123-31. PubMed ID: 12203124 [TBL] [Abstract][Full Text] [Related]
20. Relationship of sequence-specific transactivation and p53-regulated apoptosis in interleukin 3-dependent hematopoietic cells. Gottlieb E; Lindner S; Oren M Cell Growth Differ; 1996 Mar; 7(3):301-10. PubMed ID: 8838860 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]